Advertisement
Australia markets closed
  • ALL ORDS

    7,862.30
    -147.10 (-1.84%)
     
  • AUD/USD

    0.6417
    -0.0028 (-0.44%)
     
  • ASX 200

    7,612.50
    -140.00 (-1.81%)
     
  • OIL

    85.03
    -0.38 (-0.44%)
     
  • GOLD

    2,386.70
    +3.70 (+0.16%)
     
  • Bitcoin AUD

    97,833.00
    -6,175.15 (-5.94%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

The Global Bovine Serum Albumin Market is Forecast to Grow to USD 491.86 Million by 2025, at a CAGR of 3.44%

Dublin, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The "Bovine Serum Albumin Market Research Report by Preparation Method , by Form, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Bovine Serum Albumin Market is expected to grow from USD 401.38 Million in 2019 to USD 491.86 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 3.44%.

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Bovine Serum Albumin Market including BelHealth Investment Partners, LLC, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biological Industries, Itoham Yonekyu Holdings Inc., Kraeber & Co. GmbH, LGC Group, Merck KGaA, Proliant Biologicals, Promega Corporation, ProSpec-Tany TechnoGene Ltd, Rockland Immunochemicals Inc., Rocky Mountain Biologicals Inc, Serion GmbH, and Thermo Fisher Scientific Inc.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bovine Serum Albumin Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision-making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Ongoing research amplifies the research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments


Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Dynamics
5.1. Introduction
5.1.1. Drivers
5.1.1.1. Less expensive and stable nature of bovine serum albumin as a protein standard
5.1.1.2. Growing livestock industry and consequent demand generation for blood-based products
5.1.1.3. Increasing application in the food & pharmaceutical industries
5.1.2. Restraints
5.1.2.1. Rising demand for animal-free albumin products
5.1.2.2. Growing appeal to replace fetal bovine serum and its components in cell culture applications
5.1.3. Opportunities
5.1.3.1. Increasing growth opportunities in dietary protein for fat reduction
5.1.3.2. Usage in the biodegradable and edible food packaging industry
5.1.4. Challenges
5.1.4.1. Availability of counterfeit products in the diagnostic and pharmaceutical industries

6. Market Insights

7. Global Bovine Serum Albumin Market, By Preparation Method

8. Global Bovine Serum Albumin Market, By Grade

9. Global Bovine Serum Albumin Market, By Form

10. Global Bovine Serum Albumin Market, By End-User

11. Americas Bovine Serum Albumin Market

12. Asia-Pacific Bovine Serum Albumin Market

13. Europe, Middle East & Africa Bovine Serum Albumin Market

14. Competitive Landscape

15. Company Usability Profiles

  • BelHealth Investment Partners, LLC

  • Bio-Rad Laboratories, Inc.

  • Bio-Techne Corporation

  • Biological Industries

  • Itoham Yonekyu Holdings Inc.

  • Kraeber & Co. GmbH

  • LGC Group

  • Merck KGaA

  • Proliant Biologicals

  • Promega Corporation

  • ProSpec-Tany TechnoGene Ltd

  • Rockland Immunochemicals Inc.

  • Rocky Mountain Biologicals Inc

  • Serion GmbH

  • Thermo Fisher Scientific Inc.


For more information about this report visit https://www.researchandmarkets.com/r/jpkqli

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ADVERTISEMENT
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900